U.S. Transportation Stock News

NYSE:APTV
NYSE:APTVAuto Components

Does Aptiv (APTV) Offer Value After This Year’s 27% Share Price Decline?

Wondering if Aptiv's current share price reflects its true worth, or if the recent swings are masking a clearer story about value. Aptiv closed at US$57.11, with returns of a 5.2% decline over 7 days, a 1.9% decline over 30 days, a 27.2% decline year to date, but a 10.3% gain over the past year, which can leave the stock looking quite different depending on the time frame you focus on. Those mixed returns sit against a backdrop of ongoing attention on Aptiv as an auto components supplier, as...
NasdaqGS:GEOS
NasdaqGS:GEOSEnergy Services

Geospace Technologies (GEOS) Q1 Loss Of US$9.8 Million Challenges Profitability Optimism

Geospace Technologies (GEOS) opened Q1 2026 with revenue of US$25.6 million and a basic EPS loss of US$0.76, alongside a trailing twelve month basic EPS loss of US$2.17 on revenue of US$99.2 million. Over recent quarters the company has reported revenue between US$18.0 million and US$37.2 million, while EPS has ranged from a profit of US$0.66 per share in Q1 2025 to several loss-making quarters since. For investors, that mix of fluctuating topline and persistent losses keeps the attention on...
NYSE:JHG
NYSE:JHGCapital Markets

Janus Henderson Group (JHG) Earnings Double Challenging Bearish Margin And Quality Concerns

Janus Henderson Group (JHG) closed out FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$2.64, capping a trailing twelve month net income of US$798.3 million on basic EPS of US$5.25. Over the past year, total revenue has moved from US$2.5 billion on trailing basic EPS of US$2.57 to US$3.1 billion on trailing basic EPS of US$5.25, alongside an improvement in net profit margin from 16.1% to 25.8%. This puts earnings quality front and center for investors assessing the...
NYSE:PARR
NYSE:PARROil and Gas

Is It Too Late To Consider Par Pacific Holdings (PARR) After Its 255% One Year Surge?

If you are wondering whether Par Pacific Holdings at US$62.25 is still attractively priced after a strong run, the next sections will walk through what the current market price may be implying about the stock. The share price has pulled back with a 5.2% decline over the last week and a 3.7% decline over the last month, even though the year to date return stands at 73.8% and the 1 year return at 255.1%. Recent news coverage has focused on Par Pacific Holdings as an oil and gas refiner and...
NasdaqCM:ASRT
NasdaqCM:ASRTPharmaceuticals

Assertio Holdings (ASRT) Q4 Loss Of US$11.9 Million Reinforces Ongoing Bearish Earnings Narrative

Assertio Holdings (ASRT) closed out FY 2025 with Q4 revenue of US$13.5 million and basic EPS of a US$1.86 loss, alongside a trailing twelve month revenue base of US$118.7 million and basic EPS of a US$4.74 loss. Over the past year, quarterly revenue has moved between US$26.5 million and US$49.5 million, while quarterly basic EPS has ranged from a US$2.56 loss to US$1.78, leaving investors focused on how these shifts are feeding through to underlying margins. See our full analysis for Assertio...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant Targets AI Risk With Secure Services And Provable Trust Pitch

Cognizant Technology Solutions (NasdaqGS:CTSH) has introduced Secure AI Services, a suite aimed at enterprise-grade AI security and governance. The new offering focuses on securing and monitoring AI and agentic systems, with an emphasis on what the company describes as "provable trust" at scale. The launch targets risks such as model tampering and deepfake fraud as enterprises expand AI across critical workflows. For you as an investor, this launch sits at the intersection of Cognizant's...
NYSEAM:SIF
NYSEAM:SIFAerospace & Defense

SIFCO Industries (SIF) Returns To Profit In Q1 2026 And Tests Turnaround Narratives

SIFCO Industries (SIF) opened Q1 2026 with total revenue of US$24.0 million and net income of US$1.8 million, translating to basic EPS of US$0.29 for the quarter. The company has seen quarterly revenue move from US$21.7 million in Q4 2024 to US$20.9 million in Q1 2025 and then to US$24.0 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 and US$0.40 in Q1 2025 to a profit of US$0.29 in the latest period. This sets up an earnings season in which investors are likely to...
NYSE:EPAC
NYSE:EPACMachinery

Is Enerpac’s Expanded Leadership Bench Quietly Reframing the Strategic Story for EPAC?

Enerpac Tool Group Corp. recently expanded its leadership team, promoting Phil Jefferson to Executive Vice President and Chief Commercial Officer with added oversight of the Asia Pacific region, and elevating Mart Hinnen to Executive Vice President of Innovation & Heavy Industrial Technologies with responsibility for the Heavy Lifting Technology and DTA businesses. The promotions consolidate global commercial and innovation leadership under two experienced insiders, potentially sharpening...
NasdaqCM:TC
NasdaqCM:TCMedia

Token Cat (NasdaqCM:TC) Sharp H1 Loss Narrowing Tests Bearish High P/S Narrative

Token Cat (TC) has just posted its H1 2025 numbers, with revenue of C¥19.8 million and a net income loss of C¥0.7 million, translating to basic EPS of C¥5.74 loss per share, while trailing 12 month figures show revenue of C¥36.6 million and a net loss of C¥148.0 million, or C¥1,200.49 loss per share. Over recent half year periods the company has seen revenue move from C¥32.3 million in H1 2024 to C¥16.9 million in H2 2024 and then to C¥19.8 million in H1 2025. Over the same periods, EPS...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Afya’s Solid Earnings Meet Valuation Discount And AI Headwinds

Afya (NasdaqGS:AFYA) reports revenue and EBITDA growth, highlighting resilient financial performance in its latest earnings update. The Medical Practice Solutions segment faces pressure from declining active payers and stronger competition from AI driven tools. These developments point to a mixed picture for Afya, with solid headline results and emerging challenges beneath the surface. Afya operates across medical education and healthcare services in Brazil, and its latest report underlines...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Why Sanmina (SANM) Is Up 8.8% After Strong Q2 Results And New $600 Million Buyback Program

In late April 2026, Sanmina Corporation reported second-quarter fiscal 2026 results showing sales of US$4,013.27 million and net income of US$93.65 million, while outlining new revenue guidance for the third quarter and full year and expanding its capital return plans with a fresh US$600 million share repurchase authorization. Alongside this, Sanmina signaled an appetite for acquisitions that meet its return thresholds, filed a US$230.59 million employee stock offering shelf, and saw its...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts Farmers Market (SFM) Still Attractive After Recent Share Price Volatility?

For readers considering whether Sprouts Farmers Market at around US$80.99 still represents good value, or whether the key part of the move has already occurred, this article outlines what the current price may be implying. The stock has been choppy recently, with a 1% slip over the last week, a 5% gain over the last month, a modest 0.4% return year to date, and a 48.8% decline over the past year. This sits alongside a 120.3% return over three years and 212.8% over five years. These moves...
NYSE:BWA
NYSE:BWAAuto Components

Is It Too Late To Consider BorgWarner (BWA) After Its Strong 1 Year Share Price Run

Wondering if BorgWarner stock still offers value after a strong run, or if you might be turning up late to the story? The stock last closed at US$58.18, with returns of 2.1% over 7 days, 11.1% over 30 days, 24.7% year to date, 89.5% over 1 year, 54.3% over 3 years and 40.1% over 5 years. Recent coverage has focused on BorgWarner's position in auto components and how investors are treating the stock in light of the sector's ongoing focus on efficiency and electrification. This helps frame...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Has Arrowhead Pharmaceuticals (ARWR) Run Too Far After Its 488% One Year Surge

If you are wondering whether Arrowhead Pharmaceuticals at around US$77.95 is still offering value or has already run too far, this breakdown is designed to help you frame that question clearly. The stock has returned 6.1% over the past week, 27.4% over the last 30 days, 15.0% year to date, and 488.3% over the past year, which naturally raises questions about how much of the story is already priced in. Recent coverage has focused on Arrowhead Pharmaceuticals' progress in RNA interference...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Is Up 13.3% After Swing to Loss but Strong 2026 Revenue Guidance - What's Changed

Waters Corporation reported past first-quarter 2026 results with sales rising to US$1,267 million from US$662 million a year earlier, but swinging from net income of US$121 million to a net loss of US$72 million, with basic and diluted loss per share of US$0.87 from continuing operations. Alongside these results, Waters issued new guidance calling for very large second-quarter 2026 revenue of US$1.62 billion to US$1.63 billion and full-year 2026 revenue of US$6.41 billion to US$6.46 billion,...
NYSE:MAN
NYSE:MANProfessional Services

ManpowerGroup (MAN) Valuation Check After Recent Share Price Swings And Earnings Weakness

Context for ManpowerGroup after recent performance swings ManpowerGroup (MAN) has seen mixed share performance recently, with a 7.6% gain over the past month and a 16.9% decline over the past 3 months. This has put fresh attention on the stock’s current valuation. See our latest analysis for ManpowerGroup. Looking beyond the recent 7.6% 30 day share price return, ManpowerGroup’s 1 year total shareholder return of 23.3% and 5 year total shareholder return of 70.4% highlight how sentiment has...
NYSE:CVI
NYSE:CVIOil and Gas

What CVR Energy (CVI)'s Q1 Losses, Higher Throughput and Dividend Decision Mean For Shareholders

In late April 2026, CVR Energy, Inc. reported first quarter 2026 results showing sales of US$1,980 million, a larger net loss of US$192 million, higher refining throughput, a US$0.10 per share cash dividend, and new production guidance for the second quarter. This combination of stronger volumes but wider losses, alongside the decision to pay a dividend, gives investors fresh insight into the company’s balance between growth, profitability, and cash returns. We’ll now examine how higher...
NYSE:DGX
NYSE:DGXHealthcare

Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Weakness?

If you are wondering whether Quest Diagnostics at around US$190.84 per share offers good value today, it helps to step back and look at the stock through a few different valuation lenses. The share price has seen mixed recent returns, with a 1.7% decline over 7 days and a 3.0% decline over 30 days, set against a 9.8% gain year to date and 10.4% over the past year, plus longer term returns of 54.8% over 3 years and 53.1% over 5 years. Recent coverage has focused on Quest Diagnostics as a US...
NYSE:TTI
NYSE:TTIEnergy Services

Assessing TETRA Technologies (TTI) Valuation After Recent Share Price Volatility

Why TETRA Technologies Stock Is On Investors’ Radar TETRA Technologies (TTI) has drawn interest after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation and business profile. See our latest analysis for TETRA Technologies. At a share price of US$9.77, TETRA Technologies has seen a 19.9% 1 month share price return but a 16.3% 3 month share price decline, while the 1 year...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Is Capital Southwest (CSWC) Pricing Too Optimistically After Its Strong 1 Year Share Price Run?

If you are wondering whether Capital Southwest stock still offers value at its current price, this article walks through the numbers so you can judge how the valuation stacks up for yourself. With the share price at US$23.99, recent returns of 6.3% over 30 days, 7.6% year to date and 35.5% over the past year put a clear spotlight on how investors are currently pricing the stock and what that might mean for future risk and reward. Those returns sit alongside a longer record, including 89.7%...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

How Investors Are Reacting To SkyWater Technology (SKYT) Surging Q1 Sales But Deeper Net Loss

SkyWater Technology, Inc. has released its first‑quarter 2026 results, reporting sales of US$160.69 million versus US$61.3 million a year earlier, alongside a net loss of US$12.31 million and basic and diluted loss per share from continuing operations of US$0.25, both larger than the prior year. The combination of rapidly higher revenue and a wider loss profile highlights how SkyWater’s growth investments are still weighing on profitability, a pattern that investors may re‑evaluate against...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Is Up 14.1% After Mixed Q1 And Stronger SiC Outlook Has The Bull Case Changed?

Axcelis Technologies reported first-quarter 2026 revenue of US$198.96 million, slightly above the prior year, while net income and earnings per share declined meaningfully year over year. Alongside guiding to higher second-quarter revenue and earnings, Axcelis highlighted momentum in memory and silicon carbide markets and showcased its MUSIC™ implant technology at an industry conference, underlining its focus on equipment innovation. Next, we’ll examine how this combination of...
NYSE:LYB
NYSE:LYBChemicals

Is LyondellBasell (LYB) Offering Value After Strong Year-To-Date Surge And Recent Pullback

If you are trying to work out whether LyondellBasell Industries' current share price reflects its underlying value, the recent moves in the stock give you plenty to think about. The stock closed at US$71.51, with a 4.1% decline over the past week and a 10.9% decline over the past month, yet it has returned 61.1% year to date and 36.5% over the last year. Recent coverage around LyondellBasell has focused on its position within the broader chemicals sector and how investors are weighing...
NYSE:ALLE
NYSE:ALLEBuilding

Is Allegion’s Q1 Margin Hit Amid Higher Sales and Raised Guidance Altering The Investment Case For Allegion (ALLE)?

In the first quarter of 2026, Allegion reported sales of US$1,033.6 million, up from US$941.9 million a year earlier, while net income declined to US$138.1 million and diluted EPS from continuing operations eased to US$1.59. The company attributed the profit pressure to margin impacts from ERP-related production issues in its international business, even as it raised full-year 2026 revenue growth guidance to 6%–8% and projected full-year EPS of US$7.95–US$8.15. Next, we will examine how...